What does QUALIBLOOD do?

QUALIBLOOD is a research organisation in Liège. Public Limited, started on 15 November 2017, 1 establishment.

What is the address of QUALIBLOOD?

The registered office of QUALIBLOOD is located at Rue Louvrex 55-57, 4000 Liège.

Is QUALIBLOOD still active?

Not as usual. The CBE lists QUALIBLOOD with legal situation “Vrijwillige ontbinding – vereffening”.

Is QUALIBLOOD registered on Peppol?

Yes, QUALIBLOOD is registered on the Peppol network with ID 0208:0684698353.

What is the enterprise number of QUALIBLOOD?

The enterprise number of QUALIBLOOD is BE0684698353.

When was QUALIBLOOD founded?

QUALIBLOOD was founded on 15 November 2017.

Who are the directors of QUALIBLOOD?

According to the 2024 annual accounts, the directors of QUALIBLOOD are: NOSHAQ PARTNERS, Jean-Michel FOIDART, CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMUR, Bernard MASEREEL, NAMUR INVEST, Conseils, Gestion, Organisation - C.G.O.

Is QUALIBLOOD a reliable company?

Databakkes does not pass judgement; this is what the sources say: Vrijwillige ontbinding – vereffening according to the CBE, started on 15 November 2017; 4 annual accounts filed, latest fiscal year 2024; 6 directors known from the annual account.

How much profit did QUALIBLOOD make in 2024?

QUALIBLOOD recorded a loss after taxes of € 560,095 in financial year 2024.

What is the revenue of QUALIBLOOD?

As a small company, QUALIBLOOD is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € -251,401.

How much does an employee at QUALIBLOOD earn?

The average wage cost per full-time employee at QUALIBLOOD was € 59,700 in 2024: staff costs of € 394,296 for 6.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does QUALIBLOOD have?

According to the 2024 annual accounts, QUALIBLOOD has 6.6 full-time equivalents (FTE).

Does QUALIBLOOD have a website?

Yes, QUALIBLOOD has a website at qualiblood.eu.

QUALIBLOOD (Public Limited) - Liège - BE0684698353

Dossier QUALIBLOOD, printed on 29 October 2026 from databakkes.be/en/0684698353/qualiblood. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2023 and 2024.
Busy address KBO

20 other companies have their registered office at the same address; threshold 10.
Legal situation KBO

Vrijwillige ontbinding – vereffening according to the CBE.

Financials

Financial year 2024

QUALIBLOOD from Liège, company number BE0684698353, closed financial year 2024 with a result of € -560,095 after tax. For that financial year QUALIBLOOD recorded a gross margin of € -251,401 and equity of € 847,118. Compared with financial year 2023, the result moved from € -464,022 to € -560,095. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 7, 2025.

What it is worth Growing

€ 847,118

▲ € 660,593 vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -560,095

▼ 21 % more loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 199,551

▼ 52% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -483,570.

People and assets in 2024

Full-time equivalents

6.6

▲ 0.5 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 394,296

▼ 4% vs 2023

€ 59,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 84,239

▼ 32% vs 2023

Of which on lease € 44,040.

Debts at end 2024

Bank debt ≈ 21 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.1 million

▲ 89% vs 2023

€ 40,712 is repaid this year. At this pace the long-term loan is gone in ≈ 21 years.

Owed to suppliers

€ 222,048

▲ € 211,671 vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 62,817

▼ 3% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 958,273 Gross margin 2021: € 958,273 First fiscal year in the series	€ 433,553 Gross margin 2022: € 433,553 ▼ 55% vs 2021 (€ 958,273) Unfavourable step	€ 56,338 Gross margin 2023: € 56,338 ▼ 87% vs 2022 (€ 433,553) Unfavourable step	€ -251,401 Gross margin 2024: € -251,401 ▼ € 307,739 vs 2023 (€ 56,338) Unfavourable step	▼ € 307,739
Profit after taxes	€ 455,467 Profit after taxes 2021: € 455,467 First fiscal year in the series	€ -132,024 Profit after taxes 2022: € -132,024 ▼ € 587,491 vs 2021 (€ 455,467) Unfavourable step	€ -464,022 Profit after taxes 2023: € -464,022 ▼ € 331,998 vs 2022 (€ -132,024) Unfavourable step	€ -560,095 Profit after taxes 2024: € -560,095 ▼ € 96,073 vs 2023 (€ -464,022) Unfavourable step	▼ € 96,073
Equity	€ 782,571 Equity 2021: € 782,571 First fiscal year in the series	€ 650,547 Equity 2022: € 650,547 ▼ 17% vs 2021 (€ 782,571) Unfavourable step	€ 186,525 Equity 2023: € 186,525 ▼ 71% vs 2022 (€ 650,547) Unfavourable step	€ 847,118 Equity 2024: € 847,118 ▲ € 660,593 vs 2023 (€ 186,525) Favourable step	▲ € 660,593
Total debts	€ 529,327 Total debts 2021: € 529,327 First fiscal year in the series	€ 283,850 Total debts 2022: € 283,850 ▼ 46% vs 2021 (€ 529,327) Favourable step	€ 921,140 Total debts 2023: € 921,140 ▲ 225% vs 2022 (€ 283,850) Unfavourable step	€ 1,371,249 Total debts 2024: € 1,371,249 ▲ 49% vs 2023 (€ 921,140) Unfavourable step	▲ 49%
Cash	€ 750,590 Cash 2021: € 750,590 First fiscal year in the series	€ 86,994 Cash 2022: € 86,994 ▼ 88% vs 2021 (€ 750,590) Unfavourable step	€ 418,137 Cash 2023: € 418,137 ▲ € 331,144 vs 2022 (€ 86,994) Favourable step	€ 199,551 Cash 2024: € 199,551 ▼ 52% vs 2023 (€ 418,137) Unfavourable step	▼ 52%
Land & buildings	€ 34,159 Land & buildings 2021: € 34,159 First fiscal year in the series	€ 59,703 Land & buildings 2022: € 59,703 ▲ 75% vs 2021 (€ 34,159) Unchanged	€ 106,685 Land & buildings 2023: € 106,685 ▲ 79% vs 2022 (€ 59,703) Unchanged	€ 100,906 Land & buildings 2024: € 100,906 ▼ 5% vs 2023 (€ 106,685) Unchanged	▼ 5%
Retained profit	€ 672,571 Retained profit 2021: € 672,571 First fiscal year in the series	€ 540,547 Retained profit 2022: € 540,547 ▼ 20% vs 2021 (€ 672,571) Unfavourable step	€ 76,525 Retained profit 2023: € 76,525 ▼ 86% vs 2022 (€ 540,547) Unfavourable step	€ -483,570 Retained profit 2024: € -483,570 ▼ € 560,095 vs 2023 (€ 76,525) Unfavourable step	▼ € 560,095
Dividend	€ 11,000 Dividend 2021: € 11,000 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 11,000) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 163,792 Bank debt 2021: € 163,792 First fiscal year in the series	€ 125,299 Bank debt 2022: € 125,299 ▼ 24% vs 2021 (€ 163,792) Favourable step	€ 576,081 Bank debt 2023: € 576,081 ▲ € 450,782 vs 2022 (€ 125,299) Unfavourable step	€ 1,086,123 Bank debt 2024: € 1,086,123 ▲ 89% vs 2023 (€ 576,081) Unfavourable step	▲ 89%
Balance sheet total	€ 1,311,898 Balance sheet total 2021: € 1,311,898 First fiscal year in the series	€ 934,397 Balance sheet total 2022: € 934,397 ▼ 29% vs 2021 (€ 1,311,898) Unchanged	€ 1,107,665 Balance sheet total 2023: € 1,107,665 ▲ 19% vs 2022 (€ 934,397) Unchanged	€ 2,625,264 Balance sheet total 2024: € 2,625,264 ▲ 137% vs 2023 (€ 1,107,665) Unchanged	▲ 137%
Employees (FTE)	6.8 Employees (FTE) 2021: 6.8 First fiscal year in the series	7 Employees (FTE) 2022: 7 ▲ 0.2 vs 2021 (6.8) Unchanged	6.1 Employees (FTE) 2023: 6.1 ▼ 0.9 vs 2022 (7) Unchanged	6.6 Employees (FTE) 2024: 6.6 ▲ 0.5 vs 2023 (6.1) Unchanged	▲ 0.5

Key figures of QUALIBLOOD, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to QUALIBLOOD?

What happened at QUALIBLOOD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

QUALIBLOOD is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.

2030 NOSHAQ PARTNERS stepped down as director. NBB
2030 Jean-Michel FOIDART stepped down as director. NBB
2030 CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMUR stepped down as director. NBB
2030 Bernard MASEREEL stepped down as director. NBB
2030 NAMUR INVEST stepped down as director. NBB
2030 Conseils, Gestion, Organisation - C.G.O stepped down as director. NBB
May 7, 2025 New annual accounts for financial year 2024: loss of € 560,095. Source: NBB ↗
2024 NOSHAQ PARTNERS became a director. NBB

In short

From € 455,467 profit in 2021 to € 560,095 loss in 2024.

Paid € 51,379 in corporate taxes since 2021.

Best year ever: 2021, with € 455,467 profit.

On average € 9,200 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2024 annual accounts

NOSHAQ PARTNERS

Director · represented by Sabatel HÉLÈNE

Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM, VITAVERDE.BIO, HAEMERS Technologies, SPACEBEL, NOSHAQ VENTURE +169 more

since 2024 · until 2030

Jean-Michel FOIDART

Director

since 2024 · until 2030

CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMUR

Director · represented by de Saint-Hubert Marie

Also active at: Association des Soins palliatifs en Province de Namur

since 2024 · until 2030

Bernard MASEREEL

Director

Also active at: MEDIPHA

since 2024 · until 2030

NAMUR INVEST

Director · represented by OGER Maxime

Also active at: Brasserie du Bocq, GROTTES DE HAN, Stûv, BETRAMOS, INTERNATIONAL TANK MANAGEMENT TECHNOLOGIES, TILMAN, NONNA, COMMUNITY EUROPE +6 more

since 2024 · until 2030

Conseils, Gestion, Organisation - C.G.O

Director · represented by Delaunois PHILIPPE

Also active at: GROTTES DE HAN, DEQUACHIM, EUROQUARTZ, DEQUALEX, DEQUENNE CHIMIE

since 2024 · until 2030

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Louvrex 55-57

4000 Liège

2.270.012.410

Boulevard de Patience et Beaujonc 3

4000 Liège

Active since 15 November 2017

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.

All companies at this address →

EXIMPA

LM GESTION

€ 402,903 gross margin · 2025

LASERFLASH

€ 1.7 million gross margin · 2023

Agence locale pour l'Emploi de Villers-le-Bouillet

SPARX INDUSTRIES

€ 19.7 million revenue · 2024

+15 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS qualiblood.eu

Canonical: https://www.qualiblood.eu/

Technologies

AMPApacheBootstrapComplianzFont AwesomeGoogle AnalyticsGoogle MapsPHPSlickWP RocketWordPressYoast SEOYouTube EmbedjQueryjsDelivrlazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

PLANETHOSTER-8 - PlanetHoster, CA

Domain

qualiblood.eu

Registrar

PlanetHoster

Website info

HTTPS Ja

Languages EN

Features

Webshop

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number: 0684.698.353
VAT number: BE 0684.698.353
Registered office: Rue Louvrex 55-57, 4000 Liège
Names & denominations: QUALIBLOOD
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Vrijwillige ontbinding – vereffening
Start date: 15 November 2017
Peppol: Active · Active since 31 Mar 2026
Contact: qualiblood.eu [email protected]
Activities · NACE: Speur- en ontwikkelingswerk op biotechnologisch gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

QUALIBLOOD

Warning lights

Financials

What happened to QUALIBLOOD?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Details

Frequently asked questions